INTRODUCTION
responsible for the increased incidence of cardiovascular problems in this syndrome (Engstrom et al., 2003) . Therefore, MR is a potential target of hypertrophy and fibrosis.
The transcriptional activity of MR is mainly regulated by ligands such as aldosterone (Aldo) . MR resides in the cytosol and translocates into the nucleus after ligand binding. The binding complex of MR with its ligand binds to hormone response elements in the promoter of target genes, recruits co-regulatory proteins results in gene transcription (Yang and Young, 2009 ). However, post-transcriptional modifications (PTMs) such as acetylation, phosphorylation, ubiquitylation, and sumoylation play critical roles in regulating its transcriptional activity (Faus and Haendler, 2006) . Phosphorylation of MR enhances its binding affinity for DNA response elements (Massaad et al., 1999) whereas acetylation of MR inhibits recruitment of MR and Pol II on promoter of MR target genes and prevents development of hypertension (Lee et al., 2013) .
Histone deacetylases (HDACs) regulate pathological cardiac conditions such as fibrosis (Kee et al., 2006) and hypertrophy (Antos et al., 2003; Kook et al., 2003) . Several groups have showed that HDAC inhibitors can prevent cardiac hypertrophy in various animal models. For example, HDAC inhibitors increase expression of anti-hypertrophic transcription factors such as Kruppel-like factor 2 (KLF2) in cultured cardiomyocytes, which prevents cardiac hypertrophy in culture (Kee and Kook, 2009; Liao et al., 2010) . When transgenic mice that overexpress Hop are treated with HDAC inhibitor, increased cardiac mass is significantly reduced (Kook et al., 2003) . HDAC inhibitors block cardiac fibrosis through multiple mechanisms. Induction of collagen synthesis mediated by transforming growth factor-β (TGF-β) is prevented by HDAC inhibitor in cultured rat ventricular fibroblasts MR and Pol II on the ORM-1 promoter was confirmed by qRT-PCR (Fig. 5B) . Results of conventional PCR (Fig. 5C ) and qRT-PCR (Fig. 5D ) showed that enrichment of MR and Pol II on the PAI-1 promoter was increased in SHRs when compared with WKYs, which was attenuated by VPA treatment.
HDACi increased MR acetylation.
MR acetylation was investigated by western blot with anti-acetyl-lysine antibody after immunoprecipitation with anti-MR antibody. Expression of MR was not different between WKYs and SHRs. Treatment of VPA did not affect protein levels of MR; however, MR acetylation was significantly increased by VPA treatment ( Fig. 6A and 6B ). Also, we performed western blot with anti-MR antibody after immunoprecipitation using anti-ac-K antibody.
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DISCUSSION
In the present study, we demonstrated that HDACi attenuates cardiac hypertrophy and fibrosis through MR acetylation in SHRs. Our results show that HDACi increases MR acetylation which decreases the recruitment of MR and Pol II on target gene promoters, reduces the expression of MR target genes such as TNX, collagen IV, ORM-1, and PAI-1, and attenuates cardiac hypertrophy and fibrosis.
HDACs and histone acetylases (HATs) play critical roles in remodeling chromatin structures (Delcuve et al., 2012) . The status of acetylated histone and non-histone proteins such as transcription factors is controlled by the opposing actions of HATs and HDACs (Patel et al., 2011; Yang and Seto, 2007) . HDACs are emerging as targets for the treatment of several diseases including cardiac hypertrophy and heart failure (Cao et al., results also show that the rate of down-regulated genes was the highest in extracellular matrix and inflammation-related genes (Supplemental Figure. 1 ). In particular, expression of MR target genes such as TNX, collagen IV, ORM-1, and PAI-1 were decreased by VPA treatment (Fig. 3) . VPA would likely up-regulate MR corepressors which down-regulate expression of MR target genes. However, VPA treatment did not affect the expressions of MR corepressor genes (Supplemental Figure. 2).
Acetylation of steroid hormone receptors is a PTM that plays an important role in regulating their activity (Wang et al., 2011) . The androgen receptor (AR) is acetylated by Tip60, PCAF, and P300 in its hinge region (Fu et al., 2000) . Mutations in AR acetylation sites dramatically impair AR function, stimulating the expression of AR target genes that regulate prostate cancer cell growth (Gaughan et al., 2002) . When estrogen receptor alpha (ERα) is acetylated by P300 in lysine residues 266 and 268, it stimulates DNA binding activity (Kim et al., 2006) . On the other hand, acetylation of lysine residues 302 and 303 prevents its binding to ligand (Fuqua et al., 2000; Wang et al., 2001) . Glucocorticoid receptor (GR) is acetylated by CLOCK/BMAL1, which reduces its transcriptional activity (Nader et al., 2009 ), whereas it is deacetylated by HDAC2 (Ito et al., 2006) . In the present study, MR interacts with HDAC1 and HDAC2 regardless of Aldo exposure (Supplemental Figure. 4 ).
Treatment of HDACi resulted in decreased recruitment of MR and Pol II on the promoters of target genes in vivo (Fig. 5) . Ligand-bound MR is transported into the nucleus where it binds to specific hormone response elements (HRE) (Drouin et al., 1992; Walther et al., 2005) , which are located up to 10 kb upstream, or downstream from the transcriptional start site of target genes and regulates transcriptional activity (van der Laan et al., 2008; Wang et al., 2004) . Taken together, these results suggest that HDAC increases the transcriptional activity by deacetylation of MR in SHRs whereas HDACi prevents action of MR by acetylation of MR in SHRs.
Histone code modifications are important mechanisms for epigenetic regulation.
Expression of genes is epigenetically regulated by DNA methylation as well as histone modifications including methylation, acetylation, phosphorylation, and ubiquitylation (Kouzarides, 2007) . In particular, hyperacetylated histones by treatment with HDAC inhibitor increased the degree of H3Ac, which is linked with H3K4 methylation. Thus, H3K4 methylation (mono methylation, dimethylation. and trimethylation) is also increased (Nightingale et al., 2007) . We previously reported that expression of angiotensin converting enzyme (ACE), a component of the renin-angiotensin system (RAS), is regulated by histone acetylation (Lee et al., 2012) . Expression of ACE1 was up-regulated by enrichment of activating chromatin marks such as H3Ac and H3K4me3 on ACE1 promoter. Thus, HDAC inhibition had been expected to mostly increase expression of gene through increased histone acetylation. However, gene expression profiles elucidated by microarray analyses show that, among the 27,997 genes identified, 73 were up-regulated and 106 were down-regulated in the hearts of SHRs upon VPA treatment (Table. 1 and 2). The number of down-regulated genes was much more than that of up-regulated genes in SHRs after VPA treatment. Although VPA treatment increased enrichment of H3Ac and H3K4me3 on promoters of MR target genes in WKYs and SHRs (Fig. 4) , actual expression of MR target genes was decreased by VPA treatment (Fig. 3) . These findings suggest that enrichment of the promoters with H3Ac and H3K4me3 is not a sufficient condition for gene expression in the hearts of SHRs.
MR expression is detected in epithelial and non-epithelial tissues which imply for roles in physiology and pathophysiology (Viengchareun et al., 2007) . MR activation by mineralocorticoid or glucocorticoid produces oxidative stress and vascular inflammation, In summary, this study presents a mechanism by which HDACi attenuates cardiac hypertrophy and fibrosis through MR acetylation in SHRs. Acetylation of MR not only decreases the recruitment of MR and Pol II, but also expression of MR target genes which regulate hypertrophy and fibrosis. Therefore, HDACs may be a potential therapeutic target for cardiac hypertrophy and fibrosis treatments.
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This article has not been copyedited and formatted. The final version may differ from this version. Table I . VPA is supposed to induce transcriptional activation through increased histone acetylation. However, the number of down-regulated genes is more than that of up-regulated genes in SHRs after VPA treatment. In particular, the rate of down-regulated genes was the highest in extracellular matrix and inflammation-related genes.
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